Cannabinoid receptor ligands and uses thereof

Details for Australian Patent Application No. 2004232552 (hide)

Owner Pfizer Products Inc.

Inventors Carpino, Philip Albert; Dow, Robert Lee

Agent Shelston IP

Pub. Number AU-A-2004232552

PCT Pub. Number WO2004/094421

Priority 60/464,908 23.04.03 US

Filing date 13 April 2004

Wipo publication date 4 November 2004

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61P 003/04 Drugs for disorders of the metabolism

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/094421 Priority application(s): WO2004/094421

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232553-Cannabinoid receptor ligands and uses thereof

2004232551-Condensed N-heterocyclic compounds and their use as CRF receptor antagonists